Table 3 Vascular parameters among participants not using blood pressure-lowering medications

From: Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

 

Unadjusted

Adjusted for age and sex

Adjusted for age, sex and, mean arterial pressurea

NT

WH

MH

SH

NT

WH

MH

SH

NT

WH

MH

SH

(n = 194)

(n = 68)

(n = 38)

(n = 154)

(n = 194)

(n = 68)

(n = 38)

(n = 154)

(n = 194)

(n = 68)

(n = 38)

(n = 154)

Office PWV, m/s

6.60 ± 1.69

7.63 ± 2.03*

7.12 ± 1.89

7.80 ± 1.89*

6.89 ± 0.05

7.53 ± 0.09*

6.90 ± 0.12

7.54 ± 0.06*

7.31 ± 0.06

7.34 ± 0.08

7.12 ± 0.10

7.05 ± 0.07*

24 h PWV, m/s

6.40 ± 1.64

6.90 ± 1.90

7.22 ± 1.98*

7.35 ± 1.74*

6.69 ± 0.04

6.80 ± 0.07

7.00 ± 0.09*

7.09 ± 0.05*

6.94 ± 0.05

6.92 ± 0.07

6.81 ± 0.09

6.77 ± 0.06

Daytime PWV, m/s

6.47 ± 1.63

6.99 ± 1.88

7.29 ± 1.94*

7.44 ± 1.70*

6.75 ± 0.04

6.89 ± 0.07

7.07 ± 0.09*

7.19 ± 0.05*

6.99 ± 0.05

7.00 ± 0.06

6.90 ± 0.09

6.89 ± 0.06

Nighttime PWV, m/s

6.29 ± 1.67

6.78 ± 1.95

7.09 ± 2.09

7.18 ± 1.84

6.58 ± 0.05

6.68 ± 0.07

6.87 ± 0.10*

6.92 ± 0.05*

6.79 ± 0.05

6.77 ± 0.07

6.69 ± 0.10

6.66 ± 0.05

Office AIx

24.1 ± 11.7

27.7 ± 10.7

25.2 ± 11.5

27.4 ± 11.6*

23.8 ± 0.8

27.9 ± 1.3*

25.7 ± 1.7

27.6 ± 0.8*

25.2 ± 1.0

27.2 ± 1.3

26.5 ± 1.7

25.9 ± 1.1

24 h AIx

22.1 ± 8.7

22.9 ± 8.9

23.9 ± 8.1

25.1 ± 8.7*

21.9 ± 0.4

23.0 ± 0.7

24.3 ± 0.9*

25.2 ± 0.5*

23.4 ± 0.5

23.7 ± 0.7

23.1 ± 1.0

23.2 ± 0.6

Daytime AIx

23.1 ± 8.5

24.4 ± 8.4

25.4 ± 7.3

26.7 ± 8.4*

22.7 ± 0.4

24.6 ± 0.7*

26.0 ± 1.0*

26.9 ± 0.5*

24.2 ± 0.5

25.2 ± 0.7

24.9 ± 1.0

25.1 ± 0.6

Nighttime AIx

20.7 ± 11.2

20.8 ± 11.9

21.2 ± 10.6

22.3 ± 10.6

20.8 ± 0.6

20.8 ± 1.0

21.3 ± 1.3

22.1 ± 0.6

22.0 ± 0.6

21.3 ± 1.0

20.4 ± 1.3

20.7 ± 0.7

  1. Unadjusted data are presented as mean ± standard deviation, while adjusted data are presented as mean ± standard error
  2. PWV pulse wave velocity, AIx augmentation index, NT normotension, WH white-coat hypertension, MH masked hypertension, SH – sustained hypertension
  3. *P < 0.05 compared with NT; P < 0.05 compared with WH; P < 0.05 compared with MH
  4. aOffice, 24 h, daytime or nighttime mean arterial pressure values were used as covariates in the models for office, 24 h, daytime or nighttime vascular parameters, respectively